Lux participates in Multiply Labs Series B

Lux Capital participated as a returning investor in Multiply Labs' Series B, led by Patrick Soon-Shiong with NantWorks. The financing supports expansion of the company's robotic drug manufacturing platform. Other participants included AstraZeneca, Lingotto, Teradyne, Casdin Capital and Founders Fund.